TOT Biopharm International Co Ltd
01875
Company Profile
Business description
TOT Biopharm International Co Ltd is a clinical-stage biopharmaceutical company dedicated to developing and commercializing oncology drugs and therapies for patients and their families, as well as medical professionals. The company has a pipeline of oncology drug candidates, which include monoclonal antibodies (mAbs) and antibody-drug conjugates (ADCs). The company generates maximum revenues from Mainland China.
Contact
120 Changyang Street
Suzhou Industrial Park
Suzhou215024
CHNT: +86 51262965186
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
572
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,773.00 | 29.40 | 0.34% |
| CAC 40 | 7,684.72 | 6.83 | -0.09% |
| DAX 40 | 23,946.10 | 87.12 | -0.36% |
| Dow JONES (US) | 43,921.40 | 102.13 | 0.23% |
| FTSE 100 | 8,780.33 | 18.58 | -0.21% |
| HKSE | 24,072.28 | 211.87 | -0.87% |
| NASDAQ | 20,305.96 | 32.50 | 0.16% |
| Nikkei 225 | 40,487.39 | 336.60 | 0.84% |
| NZX 50 Index | 12,602.82 | 19.23 | 0.15% |
| S&P 500 | 6,182.61 | 9.54 | 0.15% |
| S&P/ASX 200 | 8,542.30 | 28.10 | 0.33% |
| SSE Composite Index | 3,444.43 | 20.20 | 0.59% |